|
罗氟司特N-氧化物市场分析报告
|
PDE4 Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application ... for psoriasis screenings, where roflumilast addresses urban air pollution ... protocols. Arcutis Biotherapeutics advances ZORYVE (roflumilast), a topical 0.3% cream posting ... 24-hour release kinetics—though oxidation sensitivities necessitate antioxidant bulks ...
Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 ... (sNDA) to broaden the indication of ZORYVE (roflumilast) cream 0.3% for the topical treatment ... molecule that can modulate the oxidative stress-mediated activation state of macrophages ...
|
|
|